These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 14003842)

  • 21. Antinucleosome antibody is a major autoantibody in localized scleroderma.
    Sato S; Kodera M; Hasegawa M; Fujimoto M; Takehara K
    Br J Dermatol; 2004 Dec; 151(6):1182-8. PubMed ID: 15606513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relations between systemic lupus erythematosis and dermatomyositis].
    SCOLARI E
    Rass Dermatol Sifilogr; 1958; 11(1):1-9. PubMed ID: 13579256
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lung and autoimmune disease--therapy].
    Hauber HP; Zabel P
    Dtsch Med Wochenschr; 2007 Aug; 132(33):1703-6. PubMed ID: 17713868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
    Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: association with connective tissue disorder severity.
    Gold DG; Miller RC; Pinn ME; Osborn TG; Petersen IA; Brown PD
    Radiother Oncol; 2008 Apr; 87(1):127-31. PubMed ID: 18158195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on connective tissue diseases in dermatology.
    Costner MI; Grau RH
    Semin Cutan Med Surg; 2006 Dec; 25(4):207-20. PubMed ID: 17174841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Symptomatic psychosis due to collagen diseases (systemic lupus erythematosus, scleroderma)].
    Ichimiya Y
    Ryoikibetsu Shokogun Shirizu; 2003; (40):360-3. PubMed ID: 14626139
    [No Abstract]   [Full Text] [Related]  

  • 28. [Liver and blood protein changes in systemic lupus erythematosus].
    BONDAR' ZA; VINOGRADOVA OM; PRISS IS
    Ter Arkh; 1958 Aug; 30(8):63-77. PubMed ID: 13592746
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights.
    Mahler M; Raijmakers R
    Autoimmun Rev; 2007 Aug; 6(7):432-7. PubMed ID: 17643929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Non SLE connective tissue diseases: general aspects and kidney].
    Doria A; Sabadini E; Sinico RA
    G Ital Nefrol; 2005; 22 Suppl 33():S11-20. PubMed ID: 16419000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.
    Ohtsuka T; Yamazaki S
    Br J Dermatol; 2004 Jun; 150(6):1091-5. PubMed ID: 15214893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis.
    Fujii H; Shimada Y; Hasegawa M; Takehara K; Sato S
    J Dermatol Sci; 2004 Jun; 35(1):43-51. PubMed ID: 15194146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects.
    Dourmishev L; Meffert H; Piazena H
    Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):230-4. PubMed ID: 15379871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical picture of disseminated lupus & generalized scleroderma].
    ROBLES GIL J
    Gac Med Mex; 1957 Nov; 87(11):835-46. PubMed ID: 13501336
    [No Abstract]   [Full Text] [Related]  

  • 35. Vasopressin cell antibodies and central diabetes insipidus in a patient with systemic lupus erythematosus and dermatomyositis.
    Kajiyama H; Terai C; De Bellis A; Bizzarro A; Bellastella A; Ohta S; Okamoto H; Uesato M; Hara M; Kamatani N
    J Rheumatol; 2004 Jun; 31(6):1218-21. PubMed ID: 15170939
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis.
    Luzi G; Diamanti AP; Germano V; Laganà B; Di Rosa R; Salemi S; Stoppacciaro A; D'Amelio R
    Clin Immunol; 2007 Nov; 125(2):127-30. PubMed ID: 17720626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Blood protein changes in disseminated lupus erythematosus].
    OLHAGEN B
    Sven Lakartidn; 1954 Oct; 51(41):2562-5. PubMed ID: 13216599
    [No Abstract]   [Full Text] [Related]  

  • 38. Systemic diseases and the lung.
    Dinwiddie R; Sonnappa S
    Paediatr Respir Rev; 2005 Sep; 6(3):181-9. PubMed ID: 16153567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute dermatomyositis and generalized scleroderma.
    TALBOTT JH
    Semin Int; 1957; 6(1):2-7. PubMed ID: 13432925
    [No Abstract]   [Full Text] [Related]  

  • 40. Scleroderma and dermatomyositis.
    SOMMERVILLE J
    Practitioner; 1954 Aug; 173(1034):151-8. PubMed ID: 13185897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.